Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2022

Nov 21, 2022

35119_dirs_2022-11-21_2ba24f21-622d-4fbc-a248-f02662f7b7c8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2022-11-17

Reporting Person: LAPOINTE ANTHONY GREGG (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-11-17 Stock Option (Right to Buy) $0.65 A 46154 Acquired 2032-11-16 Common Stock (46154) Direct

Footnotes

F1: The stock option vests ratably on each of February 17, 2023, May 17, 2023, August 17, 2023 and November 17, 2023.